HomeIBT-B • STO
add
Infant Bacterial Therapeutics AB
Previous close
kr 96.00
Day range
kr 95.60 - kr 100.50
Year range
kr 60.60 - kr 107.00
Market cap
1.28B SEK
Avg Volume
6.23K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 5.00K | -61.54% |
Operating expense | 29.80M | 22.60% |
Net income | -27.82M | -23.80% |
Net profit margin | -556.30K | -221.88% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 309.62M | 0.96% |
Total assets | 348.88M | 4.55% |
Total liabilities | 71.54M | 192.52% |
Total equity | 277.34M | — |
Shares outstanding | 13.47M | — |
Price to book | 4.66 | — |
Return on assets | -21.28% | — |
Return on capital | -25.58% | — |
Cash Flow
Net change in cash
(SEK) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -27.82M | -23.80% |
Cash from operations | -24.77M | 13.12% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -19.45M | 33.31% |
Free cash flow | -10.25M | 53.13% |
About
Founded
2011
Website
Employees
8